National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings, 5218-5219 [2020-01496]
Download as PDF
<![CDATA[
5218
Federal Register / Vol. 85, No. 19 / Wednesday, January 29, 2020 / Notices
Respondents
Max number
of respondents
Form name
Average
burden
per response
(hours)
Total max
burden
(hours)
Parents/Guardians ..........................................
Focus group protocol .....................................
Baseline survey and youth assent .................
First follow-up survey .....................................
3-month follow-up survey ...............................
Parental consent ............................................
285
2,946
730
438
4,163
1.50
1.00
0.83
0.83
0.25
428
2,946
608
365
1,041
Total .........................................................
.........................................................................
........................
........................
7,696
Youth Comparison Group Participants ...........
Please Note: No. Responses per Respondent is 1. Each form is completed one time.
Terry Clark,
Office of the Secretary, Asst Paperwork
Reduction Act Reports Clearance Officer.
[FR Doc. 2020–01573 Filed 1–28–20; 8:45 am]
BILLING CODE 4150–34–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
lotter on DSKBCFDHB2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended.
The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
Date: May 12–13, 2020.
Open: May 12, 2020, 8:30 a.m. to 12:00
p.m.
Agenda: To Present the Director’s Report
and other Scientific Presentations.
Place: Porter Neuroscience Research
Center, Building 35A, Conference Room 610–
640, 35 Convent Drive, Bethesda, MD 20892.
VerDate Sep<11>2014
17:27 Jan 28, 2020
Jkt 250001
Closed: May 12, 2020, 1:00 p.m. to 4:30
p.m.
Agenda: To review and evaluate grant
applications.
Place: Porter Neuroscience Research
Center, Building 35A, Conference Room 610–
640, 35 Convent Drive, Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757, malikk@
niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council; Digestive Diseases and Nutrition.
Date: May 12–13, 2020.
Open: May 12, 2020, 1:00 p.m. to 2:00 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: Porter Neuroscience Research
Center, Building 35A, Conference Room 610–
640, 35 Convent Drive, Bethesda, MD 20892.
Closed: May 12, 2020, 2:15 p.m. to 3:15
p.m.
Agenda: To review and evaluate grant
applications.
Place: Porter Neuroscience Research
Center, Building 35A, Conference Room 610–
640, 35 Convent Drive, Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757, malikk@
niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council; Diabetes, Endocrinology, and
Metabolic Diseases.
Date: May 12–13, 2020.
Open: May 12, 2020, 1:00 p.m. to 2:00 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: Porter Neuroscience Research
Center, Building 35A, Conference Room 610–
640, 35 Convent Drive, Bethesda, MD 20892.
Closed: May 12, 2020, 2:15 p.m. to 3:45
p.m.
Agenda: To review and evaluate grant
applications.
Place: Porter Neuroscience Research
Center, Building 35A, Conference Room 610–
640, 35 Convent Drive, Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757, malikk@
niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council; Kidney, Urologic, and Hematologic
Diseases.
Date: May 12–13, 2020.
Open: May 12, 2020, 1:00 p.m. to 2:45 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: Porter Neuroscience Research
Center, Building 35A, Conference Room 610–
640, 35 Convent Drive, Bethesda, MD 20892.
Closed: May 12, 2020, 2:45 p.m. to 3:45
p.m.
Agenda: To review and evaluate grant
applications.
Place: Porter Neuroscience Research
Center, Building 35A, Conference Room 610–
640, 35 Convent Drive, Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757, malikk@
niddk.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
stringent procedures for entrance into NIH
federal property. Visitors will be asked to
show one form of identification (for example,
a government-issued photo ID, driver’s
license, or passport) and to state the purpose
of their visit.
Information is also available on the
Institute’s/Center’s home page:
www.niddk.nih.gov/fund/divisions/DEA/
Council/coundesc.htm, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
E:\FR\FM\29JAN1.SGM
29JAN1
Federal Register / Vol. 85, No. 19 / Wednesday, January 29, 2020 / Notices
Dated: January 23, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–01496 Filed 1–28–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
lotter on DSKBCFDHB2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; Single-Site and
Pilot Clinical Trials Review Committee.
Date: March 4–5, 2020.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Carol (Chang-Sook) Kim,
Ph.D., Scientific Review Administrator,
Office of Scientific Review/DERA, National
Heart, Lung, and Blood Institute, 6701
Rockledge Drive, Room 7188, Bethesda, MD
20892–7924, 301–827–7940, carolko@
mail.nih.gov.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Transition to Independence
Review Committee.
Date: March 5–6, 2020.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Giuseppe Pintucci, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7192, Bethesda, MD 20892, 301–435–0287,
Pintuccig@nhlbi.nih.gov.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Clinical and Basic Science Review.
Date: March 19–20, 2020.
Time: 10:30 a.m. to 3:00 p.m.
VerDate Sep<11>2014
17:27 Jan 28, 2020
Jkt 250001
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn National Airport Hotel,
2650 Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: Keith A. Mintzer, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7186, Bethesda, MD 20892–7924, 301–827–
7949, mintzerk@nhlbi.nih.gov.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; Heart, Lung, and
Blood Program Project Review.
Date: March 20, 2020.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton BWI (Baltimore), 1100 Old
Elkridge Landing Road, Baltimore, MD
21090.
Contact Person: Jeffrey H. Hurst, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6701 Rockledge Drive, Room 7208, Bethesda,
MD 20892, 301–435–0303, hurstj@
nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: January 23, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–01493 Filed 1–28–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
5219
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Brain Initiative RFA
(EB–19–001; EB–19–002) Review SEP.
Date: February 19, 2020.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: John K. Hayes, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 959, Bethesda, MD
20892, (301) 496–8775, hayesj@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health, HHS)
Dated: January 23, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–01495 Filed 1–28–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Vascular and
Hematology Integrated Review Group;
Hypertension and Microcirculation Study
Section—Hypertension and Microcirculation.
Date: February 19–20, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: New Orleans Marriott, 555 Canal
Street, New Orleans, LA 70130.
Contact Person: Bukhtiar H. Shah, DVM,
Ph.D., Scientific Review Officer, Vascular
and Hematology IRG, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 4120, MSC 7802,
Bethesda, MD 20892, (301) 806–7314,
shahb@csr.nih.gov.
E:\FR\FM\29JAN1.SGM
29JAN1
]]>Agencies
[Federal Register Volume 85, Number 19 (Wednesday, January 29, 2020)]
[Notices]
[Pages 5218-5219]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01496]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of meetings of the National Diabetes
and Digestive and Kidney Diseases Advisory Council.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended.
The grant applications and the discussions could disclose confidential
trade secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council.
Date: May 12-13, 2020.
Open: May 12, 2020, 8:30 a.m. to 12:00 p.m.
Agenda: To Present the Director's Report and other Scientific
Presentations.
Place: Porter Neuroscience Research Center, Building 35A,
Conference Room 610-640, 35 Convent Drive, Bethesda, MD 20892.
Closed: May 12, 2020, 1:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Porter Neuroscience Research Center, Building 35A,
Conference Room 610-640, 35 Convent Drive, Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D., Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594-4757, [email protected].
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council; Digestive Diseases and Nutrition.
Date: May 12-13, 2020.
Open: May 12, 2020, 1:00 p.m. to 2:00 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: Porter Neuroscience Research Center, Building 35A,
Conference Room 610-640, 35 Convent Drive, Bethesda, MD 20892.
Closed: May 12, 2020, 2:15 p.m. to 3:15 p.m.
Agenda: To review and evaluate grant applications.
Place: Porter Neuroscience Research Center, Building 35A,
Conference Room 610-640, 35 Convent Drive, Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D., Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594-4757, [email protected].
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council; Diabetes, Endocrinology, and Metabolic
Diseases.
Date: May 12-13, 2020.
Open: May 12, 2020, 1:00 p.m. to 2:00 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: Porter Neuroscience Research Center, Building 35A,
Conference Room 610-640, 35 Convent Drive, Bethesda, MD 20892.
Closed: May 12, 2020, 2:15 p.m. to 3:45 p.m.
Agenda: To review and evaluate grant applications.
Place: Porter Neuroscience Research Center, Building 35A,
Conference Room 610-640, 35 Convent Drive, Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D., Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594-4757, [email protected].
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council; Kidney, Urologic, and Hematologic
Diseases.
Date: May 12-13, 2020.
Open: May 12, 2020, 1:00 p.m. to 2:45 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: Porter Neuroscience Research Center, Building 35A,
Conference Room 610-640, 35 Convent Drive, Bethesda, MD 20892.
Closed: May 12, 2020, 2:45 p.m. to 3:45 p.m.
Agenda: To review and evaluate grant applications.
Place: Porter Neuroscience Research Center, Building 35A,
Conference Room 610-640, 35 Convent Drive, Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D., Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594-4757, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has stringent procedures for
entrance into NIH federal property. Visitors will be asked to show
one form of identification (for example, a government-issued photo
ID, driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: www.niddk.nih.gov/fund/divisions/DEA/Council/coundesc.htm,
where an agenda and any additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
[[Page 5219]]
Dated: January 23, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-01496 Filed 1-28-20; 8:45 am]
BILLING CODE 4140-01-P
